Update on credit rating
Awaiting price reaction for this filing.
Eris Lifesciences has received a credit rating from India Ratings & Research for its additional bank facilities at 'IND AA' with a Stable outlook. The agency has also affirmed the company's existing ratings. This is a reissued version of an earlier press release from May 5, 2025, updated to reflect changes in the instruments or amounts covered. The IND AA rating is a strong investment-grade rating, indicating high creditworthiness. The company has not disclosed the exact amount of the new facilities in this filing.
Positive signal for shareholders — Eris Lifesciences can raise additional bank financing at a strong investment-grade rating (IND AA/Stable), reflecting solid financial health and strong lender confidence in the company.